Regeneron weight-loss drug halves muscle loss in combination with Novo's semaglutide in trial
- Posted on September 30, 2026
- By Bing News
- 0 Views
- 1 min read
In brief
Generating AI summary…
Regeneron weight-loss drug halves muscle loss in combination with Novo's semaglutide in trial
By Sriparna Roy Sept 30 (Reuters) - An experimental weight-loss drug being developed by Regeneron used in combination with Novo Nordisk's semaglutide reduced the loss of muscle mass by 50% compared with the loss seen with semaglutide alone in a study of patients with obesity, according to data being presented at a medical meeting. With the explosive popularity of GLP-1 weight-loss drugs such as
